Scott Quenneville v. HHS - Influenza, Guillain-Barre syndrome (2026)
Case summary [AI summaries can sometimes make mistakes]
On October 13, 2021, Scott Quenneville filed a petition alleging that he developed Guillain-Barre syndrome after receiving an influenza vaccine on November 16, 2020. Respondent conceded entitlement in an August 29, 2023 Rule 4(c) report, agreeing that Mr.
Quenneville satisfied the Vaccine Injury Table and QAI for GBS, timely filed his claim, received the vaccine in the United States, and suffered residual effects for more than six months. Chief Special Master Brian H.
Corcoran found entitlement on September 11, 2023. The public entitlement ruling does not give a full neurologic chronology.
The damages proffer used life-care planning and lost-earnings calculations. On January 8, 2026, the Chief Special Master awarded a lump sum of $1,007,497.30, made up of $22,275.44 in first-year life-care expenses, $776,175.36 in lost earnings, $204,000.00 for pain and suffering, and $5,046.50 in unreimbursed expenses, with future life-care payments to be provided through an annuity.
Theory of causation
Influenza vaccine November 16, 2020 causing Table GBS; adult, exact age not stated. ENTITLEMENT CONCEDED; COMPENSATED. Rule 4(c) conceded Table/QAI criteria and residual effects over six months; damages included life-care planning by respondent and petitioner life-care experts. Lump sum $1,007,497.30 ($22,275.44 first-year life care + $776,175.36 lost earnings + $204,000 pain/suffering + $5,046.50 expenses) plus future annuity life-care payments. Chief SM Brian H. Corcoran; petition October 13, 2021; damages January 8, 2026.